---
figid: PMC7753217__fonc-10-593245-g002
figtitle: IFITM3’s mode of action in cancer
organisms:
- NA
pmcid: PMC7753217
filename: fonc-10-593245-g002.jpg
figlink: pmc/articles/PMC7753217/figure/f2/
number: F2
caption: 'IFITM3’s mode of action in cancer. TGF- β pathway: IFITM3 stabilizes SMAD4
  and SMAD2/3 phosphorylation and increases transcription of downstream oncogenic
  proteins. In non-canonical TGF-β signaling pathways, IFITM3 is involved in STAT3
  signaling and activation of the p38/MAPK pathway, resulting in transcription of
  downstream oncogenic genes. JAK/STAT pathway: Upon activation of the JAK/STAT pathway
  following IFN, IFITM3 expression increases and interacts with other protein partners
  to increase transcription of downstream oncogenic and anti-inflammatory genes. PI3K
  pathway: IFITM3 interacts with PIP3 and PI3K, modulating PI3K/Akt signaling. Wnt
  pathway: IFITM3 levels are regulated by β-catenin, secondary to APC gene activation.
  In addition, KLF4 mediates IFITM3 gene expression via both direct transcriptional
  inhibition and through attenuating Wnt/β-catenin signaling. The overall outcome
  of IFITM3 involvement in these various pathways is increased cell growth and proliferation,
  invasion, and metastasis. Figure created with Biorender.com.'
papertitle: 'Malignancy and IFITM3: Friend or Foe?.'
reftext: Ushani S. Rajapaksa, et al. Front Oncol. 2020;10:593245.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9689162
figid_alias: PMC7753217__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7753217__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7753217__fonc-10-593245-g002.html
  '@type': Dataset
  description: 'IFITM3’s mode of action in cancer. TGF- β pathway: IFITM3 stabilizes
    SMAD4 and SMAD2/3 phosphorylation and increases transcription of downstream oncogenic
    proteins. In non-canonical TGF-β signaling pathways, IFITM3 is involved in STAT3
    signaling and activation of the p38/MAPK pathway, resulting in transcription of
    downstream oncogenic genes. JAK/STAT pathway: Upon activation of the JAK/STAT
    pathway following IFN, IFITM3 expression increases and interacts with other protein
    partners to increase transcription of downstream oncogenic and anti-inflammatory
    genes. PI3K pathway: IFITM3 interacts with PIP3 and PI3K, modulating PI3K/Akt
    signaling. Wnt pathway: IFITM3 levels are regulated by β-catenin, secondary to
    APC gene activation. In addition, KLF4 mediates IFITM3 gene expression via both
    direct transcriptional inhibition and through attenuating Wnt/β-catenin signaling.
    The overall outcome of IFITM3 involvement in these various pathways is increased
    cell growth and proliferation, invasion, and metastasis. Figure created with Biorender.com.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - IFNA1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - IFN1@
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IFITM3
  - STAT3
  - STAT2
  - STAT1
  - CTNNB1
  - SMAD2
  - SMAD3
  - PDK1
  - PDPK1
  - SMAD4
  - MAPK3
  - MAPK1
  - MTOR
  - KLF4
  - IKZF1
  - MIR29A
  - Tyrosine
---
